|
Chinese OTC Drugmaker Warned for Inspection Denials, GMP Issues
Fercy Personal Care Products, a Chinese OTC drugmaker, has been warned for a host of quality problems at its Jinhua, China, facility and for limiting investigators’ access to the unregistered plant.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives